← Scroll for more →
InMed Pharmaceuticals Inc. (INM)
Pharmaceutical Preparations
Latest Price
$1.63
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
2.36
P/B Ratio
0.69
Institutional Ownership
50.5% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 800.0K | $1.0M | 14.98% | -- | 2026-06-30 |
| Vivo Capital, LLC | 798.4K | $1.0M | 14.95% | -- | 2026-06-30 |
| Squadron Capital Management LLC | 325.0K | -- | 6.09% | -- | 2026-06-30 |
| Ikarian Capital, LLC | 245.0K | -- | 4.59% | -- | 2026-06-30 |
| Ursa Fund Management, LLC | 125.8K | -- | 2.36% | -- | 2026-06-30 |
| Montanova Capital, LLC | 100.0K | -- | 1.87% | -- | 2026-06-30 |
| Boothbay Fund Management, LLC | 74.2K | -- | 1.39% | -- | 2026-06-30 |
| Sabby Management, LLC | 45.0K | -- | 0.84% | -175.3K | 2026-06-30 |
| Jane Street Group, LLC | 43.1K | -- | 0.81% | +31.1K | 2026-06-30 |
| Venrock Adviser, LLC | 32.7K | -- | 0.61% | -- | 2026-06-30 |